New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
12:37 EDTX, VZ, SIG, CMCSA, NFLX, ZLC, PBPB, GOOG, TIFOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday after the S&P 500 spent the majority of the morning in positive ground. Significantly worse than expected housing data for January contributed to a lower open for the major averages, but the Dow and S&P had recovered within an hour of the opening bell. The averages hung near the flat line until just about noon, when all three declined in concert. The move lower may be related to cautious comments coming from the International Monetary Fund, but also coincided with new headlines regarding the ongoing political unrest in Ukraine. ECONOMIC EVENTS: In the U.S., the newly revamped producer price index, which now includes the wholesale cost of goods and adds services, construction, government purchases and exports, climbed 0.2% on a seasonally adjusted basis, which was above the forecast for a 0.1% increase. Housing starts dropped 16% from the prior month to an 880K annual rate in January, which was significantly worse than expected. Building permits also fell a worse-than-expected 5.4% from the prior month to a rate of 937K. COMPANY NEWS: Signet Jewelers (SIG) agreed to acquire Zale (ZLC), which operates its namesake brand as well as Kay Jewelers, Jared, and others, for about $1.4B, or $21.00 per share. Signet projected the transaction to be high single-digit percentage accretive to earnings in the first full fiscal year after the deal closes, excluding acquisition accounting adjustments and one-time transaction costs. Shares of Zale jumped 40% to trade just below $21 at midday, while Signet's stock rose more than 16%. Shares of the leading jewelry and watch retailer in terms of market capitalization, Tiffany (TIF), were up fractionally following the deal between its smaller rivals... After courts ruled against the Federal Communications Commission's last two attempts to enforce "Open Internet" rules, otherwise known as "net neutrality," on broadband providers like Verizon (VZ) and Comcast (CMCSA), the regulator said it is going back to the drawing board to craft new rules to prevent ISPs from charging companies like Netflix (NFLX) and Google (GOOG) to provide consumers of their services the highest speeds. MAJOR MOVERS: Among the notable gainers following their earnings reports were land drilling contractor Nabors Industries (NBR), which advanced 12%, and GPS maker Garmin (GRMN), which gained 8%. Among the noteworthy losers was U.S. Steel (X), which fell 7% after the U.S. Department of Commerce declined to impose tariffs on oil and natural gas pipe products from South Korea, which is the largest exporter among nine nations targeted in a complaint from the company and others in the industry. Also lower were shares of sandwich shop owner Potbelly (PBPB), which fell nearly 11% after reporting quarterly sales that missed expectations. INDEXES: Near midday, the Dow was down 34.00, or 0.21%, to 16,096.40, the Nasdaq was down 21.11, or 0.49%, to 4,251.67, and the S&P 500 was down 4.63, or 0.25%, to 1,836.13.
News For ZLC;SIG;TIF;NFLX;VZ;GOOG;CMCSA;X;PBPB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
January 12, 2015
10:17 EDTTIFTiffany price target lowered to $110 from $121 at Sterne Agee
Subscribe for More Information
10:15 EDTTIFOptions with decreasing implied volatility
Options with decreasing implied volatility: NBIX APOL NPSP BBBY INFY JCP MU TIF
10:00 EDTGOOGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:40 EDTGOOGGoogle no longer fixing older Android security flaws, WSJ reports
Subscribe for More Information
09:30 EDTTIFOn The Fly: Pre-market Movers
HIGHER: Foundation Medicine (FMI) up 138.9% following transaction with Roche (RHHBY)... Celator Pharmaceuticals (CPXX), up 19.1% after announcing promising Phase 2 data for CPX-351... Second Sight (EYES), up 16.7% after Health Canada approves Argus II retinal prosthesis system... Aegerion (AEGR), up 7.8% after reporting preliminary fourth quarter results and guidance... Express (EXPR), up 4.5% after reporting preliminary fourth quarter results. NOTABLE: NPS Pharmaceuticals (NPSP), up 8.5% following acquisition by Shire (SHPG)... Shire is down 1.1% in pre-market trading. LOWER: Arrowhead (ARWR), down 20.9% after FDA clears company to begin modified study of ARC-520 in a preliminary call of a partial clinical hold... Tiffany (TIF), down 10.4% after lowering fiscal 2014 net EPS guidance... SanDisk (SNDK), down 10.1% after lowering fourth quarter outlook... Ascena Retail (ASNA), down 5.8% after lowering fiscal 2015 adjusted EPS view... Sarepta Therapeutics (SRPT), down 5.9% after reporting long-term outcomes from Phase IIb Eteplirsen study... Loral Space & Communications (LORL), down 3.6% following a NY Post article that reported that talks to sell itself to the Ontario Teachers’ Pension Plan have ended... Southwestern Energy (SWN), down 4.2% after filing to sell 20.3M shares of stock and 26M depository shares.
09:22 EDTGOOG23andMe announces collaboration with Pfizer
Google (GOOG)-backed 23andMe announced an agreement with Pfizer (PFE) that will provide Pfizer with access to 23andMe’s research platform, including services and Research Portal analysis of 23andMe’s genotyped population of over 800,000 individuals, of which more than 80 percent have consented to participate in research. 23andMe’s Research Portal enables qualified and approved scientists outside of 23andMe the opportunity to leverage the company’s unique research model while still protecting the privacy and security of 23andMe’s customers. As a part of the agreement, the companies will collaborate on certain genome-wide association studies, surveys, and clinical trial recruitment. One of these collaborations will be a longitudinal study to better understand the genetics of lupus. This study will entail enrollment and genotyping of 5,000 people into a new lupus research community, and include the integration of medical records, targeted bio-sampling along with genetic information for all participants. This announcement follows a collaboration between 23andMe and Pfizer to enroll 10,000 people with Inflammatory Bowel Disease in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Nearly 4,000 patients have been enrolled in the community since August 2014.
09:04 EDTNFLXAmazon wins first Golden Globe for 'Transparent,' Business Insider reports
Subscribe for More Information
08:21 EDTGOOGApple poised to gain market share, says JMP Securities
Subscribe for More Information
08:18 EDTNFLXNetflix January weekly volatility elevated into Q4 and outlook
Subscribe for More Information
08:02 EDTGOOGGoogle shares undervalued, says Bernstein
Subscribe for More Information
07:47 EDTTIFTiffany volatility elevated into lower 2014 earnings outlook
Subscribe for More Information
07:46 EDTSIGStephens Events at 17th Annual ICR XChange Conference
Subscribe for More Information
07:38 EDTGOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
07:35 EDTVZNational Retail Federation to hold a trade show
Subscribe for More Information
07:04 EDTTIFTiffany cuts FY14 net EPS view to $4.15-$4.20 from $4.20-$4.30
Subscribe for More Information
07:03 EDTTIFTiffany reports holiday period worldwide net sales $1.02B
Subscribe for More Information
06:46 EDTGOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
06:16 EDTVZSpherix announces trial date for case against Verizon set for May 18
Subscribe for More Information
06:06 EDTVZSoftcard cuts 60 employees in restructuring, Re/code reports
Subscribe for More Information
05:55 EDTSIGSignet Jewelers management to meet with Cowen
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use